BASELINE LEUKOCYTE COUNT AND ACUTE CORONARY SYNDROME: PREDICTOR OF ADVERSE CARDIAC EVENTS, LONG AND SHORT TERM MORTALITY AND ASSOCIATION WITH TRADITIONAL RISK FACTORS, CARDIAC BIOMARKERS AND CREACTIVE PROTEIN
AbstractBackground: The elevated WBC count has been accepted as part of healing response followingmyocardial infarction as well as a predictor of adverse cardiovascular events. The study was designedto find out correlation between WBC count and coronary risk factors, cardiac biomarkers, C-reactiveprotein (CRP), incidence of adverse cardiac events and mortality in patients of ACS in Pakistan.Methods: One hundred and thirty-three patients of ACS were stratified according to WBC categories,WBC1 (<7000/mm3), WBC2 (7100–10,000/mm3) and WBC3 (>10,000/mm3). The WBCs werecounted on admission by Sysmex cell counter, CRP by immunoturbidimetric method, and CK-MB andTrop-I by enzyme immunoassay. Adverse cardiac events and mortality were recorded for 12 months offollow up period. Results: Long term mortality in patients with ACS was 6.4% in WBC1, 18.2% inWBC2 and 40.9% in WBC3 categories, while short term mortality was 2.6%, 3.0% and 18.2% inWBC1, WBC2, and WBC3 categories respectively. Relative to patients in lower 2 WBC categories,patients in the highest category were 7 times more likely to die during 30 days (HR 7.83, p=0.017) andmore than 9 times during the total follow up period (HR 9.42, p<0.001). Cox regression analysisshowed WBC3 a strong independent predictor of mortality (HR 6.36, p=0.016). WBC count showed apositive correlation with coronary risk factors, cardiac biomarkers and CRP. Conclusion: WBC countis a strong independent predictor of mortality in patients with ACS and has positive correlation withcoronary risk factors, cardiac biomarkers and CRP.Keywords: Acute coronary syndrome, WBCs, Mortality, C-reactive protein
Haim M, Boyko V, Goldbourt U, Battler A, Behar S.
Predictive value of elevated white cell count in patients with
preexisting coronary heart disease. Arch Intern Med
Natalie K, Wolfgang K. Biomarkers of outcome from
cardiovascular disease. Curr Opin Crit Care 2006;12:412–9.
Grzybowski M, Welch RD, Parson L, Ndumele CE, Chen E,
Zalenski R, et al. The association between white blood cell
count and acute myocardial infarction in hospital mortality:
finding from the National Registry of myocardial infarction.
Acad Emerg Med 2004;11:1049–60.
Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte
count and coronary heart disease implications for risk
assessment. J Am Coll Cardiol 2004:44;1945–56.
Nunez J, Nunez E, Sanchis J, Bodi V, Llacer A. Prognostic
value of leukocytosis in acute coronary syndrome: the
Cinderella of the inflammatory markers. Curr Med Chem
Laurie GF, Lamberg L. The leukocyte count, a measure and
predictor of coronary events. Am J Crit Care 2007;16:401–4.
Myocardial infarction redefined. A consensus document of
the joint European Society of Cardiology / American College
of Cardiology Committee for the redefinition of myocardial
infarction. Eur Heart J 2000;21:1502–13.
Haines AP, Howarth D, North WR, Goldenberg E, Stirling
Y, Meade TW, et al. Haemostatic variables and the outcome
of myocardial infarction. Thromb Haemost 1985;50:800–3.
Cannon CP, McCabe CH, Wilcox RG, Bentely JH,
Braunwald E. Association of white blood cell count with
increase mortality in acute myocardial infarction and unstable
angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol
Ndrepepa G, Braun S, Lijima R, Keta D, Byrne RA, Schulz
S, et al. Total leukocyte count but not C-reactive protein
predicts one year mortality in patients with acute coronary
syndromes treated with percutaneous coronary intervention.
Clin Sci (Lond) 2009;116:651–8.
Muller C, Neumann FJ, Perruchoud AP, Buettner HJ. White
blood cell count and long term mortality after non-ST
elevation acute coronary syndrome treated with very early
revascularization. Heart 2003;89:389–92.
Hung MJ, Cherng WJ. Comparison of white cell count in
acute myocardial infarction patients with significant and
insignificant coronary artery disease. Am J Cardiol
Morange PE, Simon C, Alessi MC, Luc G, Arveiler D,
Ferrieres J, et al. Endothelial cell markers and risk of
coronary heart disease: the prospective epidemiological study
of myocardial infarction (PRIME) study. Circulation
Avramkis G, Papadimitraki E, Papakonstandinou D, Liakou
K, Zidianakis M, Dermitzakis A , et al. Platelets and white
cell subpopulations among patients with myocardial
infarction and unstable angina. Platelets 2007;18:16–23.
Byrne CE, Fitzgerald A, Canon CP, Fitzgerald DJ, Sheilds
DC. Elevated white cell count in acute coronary syndromes:
relationship to variants in inflammatory and thrombotic
genes. BMC Med Genet 2004;5:13.
Malika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role f noval risk factors: a clinicochemical
perspective. Angiology 2007;58:513–22.
Etrl G, Frantz S. Wound model of myocardial infarction. Am
J Physiol Heart Circ Physiol 2005;288:H981–3.
Capuano V, Lamaida N, DeMartino M, Mazzotta G.
Association between white blood cell count and risk factors
of coronary artery disease. G Ital Cardiol 1995;25:1145–52.